Modifying sunitinib schedule in advanced kidney cancer patients: Reflections from the results of the renal EFFECT trial.

With the use of the fixed dosing regimen, similarly to the population pharmacokinetic study addressed above, the authors found a highly significant correlation between severe sunitinib-related toxicity and patient characteristics such as BSA, female gender, and high age ( 5 ).

also in 132,142 other papers